Healthlead PCL (BKK:HL)

Market Cap	1.49B -11.8%
Revenue (ttm)	2.29B +8.8%
Net Income	75.94M -5.2%
EPS	0.28 -6.2%
Shares Out	254.30M
PE Ratio	20.86
Forward PE	n/a
Dividend	0.22 (3.76%)
Ex-Dividend Date	Mar 11, 2026

Volume	80,209
Open	5.75
Previous Close	5.85
Day's Range	5.70 - 5.75
52-Week Range	5.40 - 8.45
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi,...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2018
• Employees: 3
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2025, Healthlead PCL's revenue was 2.27 billion, an increase of 12.85% compared to the previous year's 2.01 billion. Earnings were 77.86 million, a decrease of -0.52%.